Publications

Showing

0

out of

0

results

Isobaric Quantification of Cerebrospinal Fluid Amyloid-β Peptides in Alzheimer's Disease: C-Terminal Truncation Relates to Early Measures of Neurodegeneration.

Rogeberg M, Almdahl IS, Wettergreen M,

June 10, 2015

5-HT1B and other related serotonergic proteins are altered in APPswe mutation.

Tajeddinn W, Persson T, Maioli S,

June 4, 2015

Impact of the environment on multiple sclerosis.

Løken-Amsrud KI, Lossius A, Torkildsen Ø, Holmøy T.

May 18, 2015

Prevalence of cerebral amyloid pathology in persons without Cognitive impairment and dementia: a meta-analysis.

Jansen WJ, Ossenkoppele R, Knol DL,

May 18, 2015

Barriers and Facilitators Related to Rehabilitation Stays in Multiple Sclerosis: A Qualitative Study.

Helland CB, Holmøy T, Gulbrandsen P.

April 30, 2015

Genome-wide analysis of attention deficit hyperactivity disorder in Norway.

Zayats T, Athanasiu L, Sonderby I,

April 12, 2015

First administration of the Fc-attenuated anti-β amyloid antibody GSK933776 to patients with mild Alzheimer's disease: a randomized, placebo-controlled study.

Andreasen N, Simeoni M, Ostlund H,

March 18, 2015

Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis.

Røsjø E, Myhr KM, Løken-Amsrud KI,

March 14, 2015

The assessment of carotid atherosclerosis using a new multipurpose ultrasound probe.

Evensen K, Dahl A, Ronning OM, Russell D.

February 28, 2015

Menstrual versus non-menstrual attacks of migraine without aura in women with and without menstrual migraine.

Vetvik KG, Benth JŠ, MacGregor EA,

January 11, 2015